604 Potential Applications of Nanozymes in Treatment of Pigment Skin Diseases

Nicole Lizza,Benjamin Gallant,Ryan Garrity,Jeanine Justiniano,Meiman Peng,Yali Cui,Yinsheng Wan

DOI: https://doi.org/10.1016/j.jid.2016.02.644

2016-01-01

Abstract:Vitiligo and melanoma are two pigment skin diseases with opposite causes. Vitiligo is due to the loss of healthy melanocytes and melanoma results from overproliferation of mutated or transformed melanocytes. Our studies have shown that human melanocytes are sensitive to oxidative stress due to lack of antioxidase activity and melanoma cells are more resistant to oxidative stress due to constitutive activity of mTOR and overexpression of antioxidases such as Catalases and SODs. Recent studies have shown that some of nanopartilces exhibit activities of anti-oxidases such as peroxidase, catalase and SODs. In this study, we investigated three available nanoparticles and their anti-oxidase activities and effects on culture human melanocytes and melanoma cells. We found that iron oxide nanoparticles from NN-Labs and Goldmag Biotech and gold nanoparticles have peroxidase and SOD activity in test tubes. However, none of the nanoparticles shows catalase activity. In vitro test showed that those iron nanoparticles have no effects on the proliferation of human melanocytes and melanoma cells. Higher concentration of nanoparticles could induce apoptosis of human melanocytes. Further biochemical studies demonstrated that nanoparticles have no effect of mTOR activity and expression of catalase and SOD1 and SOD2. We also observed that those nanoparticles have marginal effect on the cellular physical behavior. Collectively, our data suggest that those nanoparticles acting as nanozymes may have potential applications in the treatment of pigment skin diseases.